SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Amazon Natural (AZNT) -- Ignore unavailable to you. Want to Upgrade?


To: zonkie who wrote (3627)9/4/1998 6:52:00 PM
From: Cavalry  Respond to of 26163
 
great post, honest and human, let's explore this and find out.
had 3 conversations with mike sylver ever covered a lot of ground
so this is a discussion with a disclaimer of i believe this is what he told me
1 can they get some type approval in brazil,
then come in under something and get approval in 30 days
2 if someone turns in t.o.n. to fda does fda have to test at fda's expense and if it passes does fda need to give some form of approval.
lets hammer out a tight list of questions and get definitive clarification from company if we can.

saw finacials which basically said we think we are covered under deshea.

how bout if posters give their arguments in one post/ trouble for aznt
or big potential for aznt investors.

the final say to company stance must come from aznt though, agreed.

j



To: zonkie who wrote (3627)9/4/1998 6:56:00 PM
From: Cavalry  Respond to of 26163
 
this isn't about mystique of amazon for me, i see a market void which
might be created if aspertame comes under fire and saccarine is already under fire for causing cancer in rats,
something has to fill this void, what else besides stevia and t.o.n.
even exist as possible alternatives?
cav